Microbial Composition of Breast Milk Collected From Healthy Turkish Women
Evaluation of Microbial Composition in Human Milk From Healthy Women in the Turkish Population: an Observational Cross-sectional Study
1 other identifier
observational
20
1 country
1
Brief Summary
Breast milk is an optimal source of nutrients for newborns as well as a potential source of bacteria for the intestinal microbiota. However, there are limited number of studies evaluating the relationship between maternal nutrition, breast milk and neonatal intestinal microbiota.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 5, 2019
CompletedFirst Submitted
Initial submission to the registry
August 27, 2019
CompletedFirst Posted
Study publicly available on registry
August 28, 2019
CompletedAugust 28, 2019
August 1, 2019
4 months
August 27, 2019
August 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Microbial abundance and diversity
The microbial composition of the breast milk samples was determined by 16S rRNA (ribosomal ribonucleic acid) gene sequencing analysis.
at 16 day postpartum
Eligibility Criteria
20 healthy women who were at 16. day postpartum
You may qualify if:
- Singleton pregnancy
- Age 19-35 years
- At weeks of 30-36 gestation
- No history of acute or chronic diseases
- Term delivery
You may not qualify if:
- Alcohol use
- Smoking
- Gestational diabetes
- Type 1 and 2 diabetes
- Preeclampsia
- Polycystic ovary
- Syndrome
- Thyroid and parathyroid disease
- Metabolic bone or kidney disease
- Abnormal liver function
- Multiple pregnancy
- Premature and postmature labor
- Having chemotherapy
- Taking drugs such as antibiotics and probiotics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Turkey (Türkiye)
Related Publications (6)
Murphy K, Curley D, O'Callaghan TF, O'Shea CA, Dempsey EM, O'Toole PW, Ross RP, Ryan CA, Stanton C. The Composition of Human Milk and Infant Faecal Microbiota Over the First Three Months of Life: A Pilot Study. Sci Rep. 2017 Jan 17;7:40597. doi: 10.1038/srep40597.
PMID: 28094284RESULTFitzstevens JL, Smith KC, Hagadorn JI, Caimano MJ, Matson AP, Brownell EA. Systematic Review of the Human Milk Microbiota. Nutr Clin Pract. 2017 Jun;32(3):354-364. doi: 10.1177/0884533616670150. Epub 2016 Sep 27.
PMID: 27679525RESULTJost T, Lacroix C, Braegger C, Chassard C. Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. Br J Nutr. 2013 Oct;110(7):1253-62. doi: 10.1017/S0007114513000597. Epub 2013 Mar 14.
PMID: 23507238RESULTHunt KM, Foster JA, Forney LJ, Schutte UM, Beck DL, Abdo Z, Fox LK, Williams JE, McGuire MK, McGuire MA. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One. 2011;6(6):e21313. doi: 10.1371/journal.pone.0021313. Epub 2011 Jun 17.
PMID: 21695057RESULTChen PW, Lin YL, Huang MS. Profiles of commensal and opportunistic bacteria in human milk from healthy donors in Taiwan. J Food Drug Anal. 2018 Oct;26(4):1235-1244. doi: 10.1016/j.jfda.2018.03.004. Epub 2018 Apr 5.
PMID: 30249322RESULTDamaceno QS, Souza JP, Nicoli JR, Paula RL, Assis GB, Figueiredo HC, Azevedo V, Martins FS. Evaluation of Potential Probiotics Isolated from Human Milk and Colostrum. Probiotics Antimicrob Proteins. 2017 Dec;9(4):371-379. doi: 10.1007/s12602-017-9270-1.
PMID: 28374172RESULT
Biospecimen
Breast Milk
Study Officials
- PRINCIPAL INVESTIGATOR
Gülhan SAMUR, Professor
Hacettepe University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
August 27, 2019
First Posted
August 28, 2019
Study Start
May 5, 2018
Primary Completion
September 5, 2018
Study Completion
July 5, 2019
Last Updated
August 28, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share